Uncategorized

Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica

by Business Wire • 2021/07/27 • 0 Comments

NASHVILLE, Tenn. & MENDRISIO, Switzerland--(BUSINESS WIRE)---- $HROW--Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica

Full Story →

← Ocular Hypertension Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com

IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer and Eric Carter, M.D., Ph.D., as Chief Medical Officer →

Post navigation